Ignite Creation Date:
2024-07-17 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494475
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
GBS-NNNN2 50 µg of Each Fusion Protein GBS-NN and GBS-NN2 in Combination With 500 µg Aluminum as Alhydrogel Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age
Sponsor:
Organization:
Minervax ApS
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
564
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: